Cannabis Bioscience International Holdings Past Earnings Performance
Past criteria checks 0/6
Cannabis Bioscience International Holdings's earnings have been declining at an average annual rate of -19.5%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been declining at an average rate of 37.3% per year.
Key information
-19.5%
Earnings growth rate
-12.9%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | -37.3% |
| Return on equity | n/a |
| Net Margin | -360.7% |
| Last Earnings Update | 29 Feb 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cannabis Bioscience International Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 29 Feb 24 | 0 | -1 | 1 | 0 |
| 30 Nov 23 | 0 | -1 | 1 | 0 |
| 31 Aug 23 | 0 | -1 | 1 | 0 |
| 31 May 23 | 0 | -1 | 1 | 0 |
| 28 Feb 23 | 0 | -1 | 1 | 0 |
| 30 Nov 22 | 0 | -1 | 1 | 0 |
| 31 Aug 22 | 0 | -1 | 1 | 0 |
| 31 May 22 | 0 | -1 | 1 | 0 |
| 28 Feb 22 | 0 | -1 | 1 | 0 |
| 31 May 21 | 1 | 0 | 1 | 0 |
| 31 May 20 | 0 | -1 | 1 | 0 |
Quality Earnings: CBIH is currently unprofitable.
Growing Profit Margin: CBIH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CBIH is unprofitable, and losses have increased over the past 5 years at a rate of 19.5% per year.
Accelerating Growth: Unable to compare CBIH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CBIH is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-6.6%).
Return on Equity
High ROE: CBIH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.